PETRINI, MASSIMILIANO
PETRINI, MASSIMILIANO
Dip. SCIENZE CLINICHE E BIOLOGICHE (attivo dal 01/01/1900 al 30/04/2013)
Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients
2006-01-01 Ridolfi R; Petrini M; Fiammenghi L; Stefanelli M; Ridolfi L; Ballardini M; Migliori G; Riccobon A.
In vitro and in vivo monitoring of a DC vaccination trial
2005-01-01 Riccobon A; Fiorentini G; Ridolfi L; Petrini M; Fiammenghi L; Stefanelli M; Galassi R; Moretti A; Bertocco M and Ridolfi R.
Tumor endothelial marker 8 (TEM8) gene expression in proangiogenic and cell migratory programs
2006-01-01 Venanzi FM; Gabrielli F; Riccobon A; Petrini M; Fiammenghi L; Stefanelli M; Ridolfi L; Ridolfi R; Cesca M; Concetti A
Tumor endothelial marker 8 expression levels in dendritic cell-based cancer vaccines are related to clinical outcome.
2010-01-01 Venanzi FM; Petrini M; Fiammenghi L; Bolli E; Granato AM; Ridolfi L; Gabrielli F; Barucca A; Concetti A; Ridolfi R; Riccobon A.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients | 2006 | Ridolfi R; Petrini M; Fiammenghi L; Stefanelli M; Ridolfi L; Ballardini M; Migliori G; Riccobon A. | |
In vitro and in vivo monitoring of a DC vaccination trial | 2005 | Riccobon A; Fiorentini G; Ridolfi L; Petrini M; Fiammenghi L; Stefanelli M; Galassi R; Moretti A; Bertocco M and Ridolfi R. | |
Tumor endothelial marker 8 (TEM8) gene expression in proangiogenic and cell migratory programs | 2006 | Venanzi FM; Gabrielli F; Riccobon A; Petrini M; Fiammenghi L; Stefanelli M; Ridolfi L; Ridolfi R; Cesca M; Concetti A | |
Tumor endothelial marker 8 expression levels in dendritic cell-based cancer vaccines are related to clinical outcome. | 2010 | Venanzi FM; Petrini M; Fiammenghi L; Bolli E; Granato AM; Ridolfi L; Gabrielli F; Barucca A; Concetti A; Ridolfi R; Riccobon A. |